Publication | Open Access

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Sakk 77/08HepatologyMedicinePathologyLiver CancerCancer TreatmentOncologyRadiation OncologySasl 29Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma